4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ALBANY MOLECULAR RESEARCH INC
- Publication Date
- 2003-04-23
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
field of invention
[0001] The present invention relates to compounds, compositions, methods and the use of said compounds in combination therapy for the treatment of various neurological and psychiatric disorders. In particular, the present invention relates to compounds, compositions and methods wherein said compounds are novel 4-phenyl substituted tetrahydroisoquinoline derivatives. Background of the invention
[0002] Serotonin, dopamine and norepinephrine are known to be important chemical messengers involved in the transmission of nerve impulses in the brain. These messengers are released and received at specific sites in the presynaptic cell to complete the transmission of impulses at specific sites in the postsynaptic cell. They are then terminated by metabolism or by uptake into presynaptic cells. Drugs that block the uptake of any of these chemical messengers by presynaptic bodies in the brain would be useful in alleviating diseases associated with reduced levels ...